Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinjing Biotechnology is a synthetic biology company based in Suzhou, China, that provides high-throughput DNA synthesis and molecular biology services. The company offers a comprehensive suite of products including gene synthesis, primer synthesis, next-generation sequencing (NGS), and specialized molecular biology reagents. By leveraging advanced synthesis and assembly technologies, Jinjing Biotechnology supports research and development across the pharmaceutical, agricultural, and industrial biotechnology sectors. Their services are designed to accelerate the design-build-test cycle for researchers globally, positioning them as a key service provider in the synthetic biology ecosystem. The company operates out of the Suzhou Industrial Park, utilizing state-of-the-art facilities to ensure high-quality and efficient production of genetic materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinjing Biotechnology.